Study details
Enrolling now
RICH Trial
VA Office of Research and Development
NCT IDNCT04982419ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2/3
Target enrollment
240
Study length
about 7.4 years
Ages
18+
Locations
3 sites in PA, TX, VA
What this study is about
Researchers are testing if remote ischemic preconditioning, a device-based treatment, can protect the kidneys from damage during procedures like cardiac catheterization. The trial will involve patients with congestive heart failure undergoing these procedures and compare them to those receiving a sham treatment.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Remote ischemic preconditioning
- 2.Use Sham remote ischemic conditioning
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Secondary: 6 minute walk distance
Body systems
Renal, Cardiology / Heart